P4.16 The impact of point-of-care management on the transmission of anogenital gonococcal infections among men who have sex with men in amsterdam: a mathematical modelling and cost-effectiveness study

Autor: M Bartelsman, K Vaughan, Van Rooijen Ms, De Vries Hjc, M Xiridou

Publikováno v: Behavioural and Social Science Research.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5962aa4df352a613c6e592aa64169c01
https://doi.org/10.1136/sextrans-2017-053264.513

Is rectal douching and sharing douching equipment associated with anorectal chlamydia and gonorrhoea? A cross-sectional study among men who have sex with men

Autor: Achterbergh, RCA, van der Helm, JJ, van den Boom, W, Heijman, T, Stolte, IG, van Rooijen, MS, de Vries, HJC

Publikováno v: Sexually Transmitted Infections; 2017, Vol. 93 Issue: 6 p431-437, 7p

Macrolide-Resistant Mycoplasma genitalium Impairs Clinical Improvement of Male Urethritis After Empirical Treatment.

Autor: Braam JF; From the Department of Infectious Diseases, Public Health Service of Amsterdam., van Dam AP, Bruisten SM, van Rooijen MS; From the Department of Infectious Diseases, Public Health Service of Amsterdam., de Vries HJC, Schim van der Loeff MF, Vergunst CE

Publikováno v: Sexually transmitted diseases [Sex Transm Dis] 2022 May 01; Vol. 49 (5), pp. 360-367.

Decreased Time to Viral Suppression After Implementation of Targeted Testing and Immediate Initiation of Treatment of Acute Human Immunodeficiency Virus Infection Among Men Who Have Sex With Men in Amsterdam.

Autor: Dijkstra M; Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands., van Rooijen MS; Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands., Hillebregt MM; Stichting HIV Monitoring, Amsterdam, The Netherlands., van Sighem A; Stichting HIV Monitoring, Amsterdam, The Netherlands., Smit C; Stichting HIV Monitoring, Amsterdam, The Netherlands., Hogewoning A; Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands., Davidovich U; Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands., Heijman T; Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands., Hoornenborg E; Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands., Reiss P; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.; Stichting HIV Monitoring, Amsterdam, The Netherlands.; Department of Global Health, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands., van der Valk M; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands., Prins M; Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands., Prins JM; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands., Schim van der Loeff MF; Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands., de Bree GJ; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jun 01; Vol. 72 (11), pp. 1952-1960.

Evaluating the prevalence and risk factors for macrolide resistance in Mycoplasma genitalium using a newly developed qPCR assay.

Autor: Braam JF; Department of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, The Netherlands., Hetem DJ; Department of Medical Microbiology, Haaglanden Medical Center, The Hague, The Netherlands., Vergunst CE; Department of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, The Netherlands.; Department of Dermatology, NWZ Den Helder, Den Helder, The Netherlands., Kuizenga Wessel S; Department of Infectious diseases, Public Health Service, The Hague, The Netherlands., van Rooijen MS; Department of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, The Netherlands., Nijhuis RHT; Department of Medical Microbiology, Haaglanden Medical Center, The Hague, The Netherlands.; Laboratory for Medical microbiology and immunology, Meander Medical Center, Amersfoort, The Netherlands., Schim van der Loeff MF; Department of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, The Netherlands.; Department of Internal Medicine, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam University Medical Center (UMC), Amsterdam, The Netherlands., van Dam AP; Department of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam University Medical Center (UMC), Amsterdam, The Netherlands., Bruisten SM; Department of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam University Medical Center (UMC), Amsterdam, The Netherlands.

Publikováno v: PloS one [PLoS One] 2020 Oct 20; Vol. 15 (10), pp. e0240836. Date of Electronic Publication: 2020 Oct 20 (Print Publication: 2020).